PubRank

Fulvio Della Ragione

Author PubWeight™ 27.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle 2007 1.34
2 Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. Blood 2005 1.26
3 Resveratrol: from basic science to the clinic. Cell Cycle 2007 1.23
4 Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat 2013 1.18
5 p57(Kip2) and cancer: time for a critical appraisal. Mol Cancer Res 2011 1.13
6 Targeting p27Kip1 protein: its relevance in the therapy of human cancer. Expert Opin Ther Targets 2011 1.07
7 The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood 2005 1.02
8 Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem 2003 1.00
9 Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation. Cancer Res 2006 0.99
10 Resveratrol: from basic studies to bedside. Cancer Treat Res 2014 0.94
11 In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant 2007 0.88
12 P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases. Cell Cycle 2014 0.88
13 Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation. Mol Cell Biochem 2003 0.88
14 Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant. Hum Mutat 2003 0.88
15 The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. PLoS One 2011 0.87
16 Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene. Orphanet J Rare Dis 2011 0.86
17 EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One 2010 0.85
18 Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol Dial Transplant 2005 0.84
19 Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma. Haematologica 2002 0.84
20 p57Kip2 is a downstream effector of BCR-ABL kinase inhibitors in chronic myelogenous leukemia cells. Carcinogenesis 2010 0.84
21 Beta-spectrinBari: a truncated beta-chain responsible for dominant hereditary spherocytosis. Haematologica 2009 0.83
22 Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Carcinogenesis 2008 0.82
23 Erythropoietin receptors on cancer cells: a still open question. J Clin Oncol 2007 0.82
24 The HIF2A gene in familial erythrocytosis. N Engl J Med 2008 0.82
25 Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. Haematologica 2013 0.81
26 Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition. Blood 2002 0.79
27 Development and performance analysis of PCL/silica nanocomposites for bone regeneration. J Mater Sci Mater Med 2010 0.79
28 HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. J Nephrol 2013 0.78
29 Resveratrol and cancer treatment: is hormesis a yet unsolved matter? Curr Pharm Des 2013 0.78
30 Vitamin A and infancy. Biochemical, functional, and clinical aspects. Vitam Horm 2003 0.77
31 Genes transcriptionally modulated by interferon alpha2a correlate with the cytokine activity. Haematologica 2004 0.77
32 Development of innovative biopolymers and related composites for bone tissue regeneration: study of their interaction with human osteoprogenitor cells. J Appl Biomater Funct Mater 2012 0.75
33 Cell division cycle manipulation and cancer treatment: a solid promise or just a dream? Haematologica 2002 0.75
34 Naturally occurring molecules and anticancer combination therapies in the era of personalized medicine and economic crisis. Curr Pharm Des 2013 0.75